Emerging Role of Fibroblast Growth Factors 15/19 and 21 as Metabolic Integrators in the Liver

被引：98
|
作者：
Cicione, Claudia [1 ]
Degirolamo, Chiara [1 ]
Moschetta, Antonio [1 ,2 ,3 ]
机构：
[1] Consorzio Mario Negri Sud, Dept Translat Pharmacol, Lab Lipid Metab & Canc, Santa Maria Imbaro, CH, Italy
[2] Univ Bari, Clin Med A Murri, Dept Internal & Publ Med, I-66030 Chieti, Italy
[3] Natl Canc Inst Giovanni Paolo II, Bari, Italy
来源：
HEPATOLOGY | 2012年 / 56卷 / 06期
关键词：
ACTIVATED-RECEPTOR-GAMMA; BILE-ACID SYNTHESIS; BETA-KLOTHO; PPAR-ALPHA; HEPATOCELLULAR-CARCINOMA; CIRCADIAN-RHYTHM; TRANSGENIC MICE; MOUSE MODEL; EXPRESSION; FGF21;
D O I：
10.1002/hep.25929
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fibroblast growth factors (FGFs) 15/19 and 21 belong to the FGF endocrine subfamily. They present the intriguing characteristic to be transcribed and secreted in certain tissues and to act as hormones. The insulin-mimetic properties of FGF21 and the regulatory role of FGF15/19 in bile acid and glucose homeostasis endorse these hormones as druggable targets in metabolic disorders. Here, we present details on discoveries, identification, transcriptional regulation, and mechanism of actions of FGF15/19 and FGF21 with a critical perspective view on their putative role as metabolic integrators in the liver. (HEPATOLOGY 2012;56:2404-2411)
引用
收藏
页码：2404 / 2411
页数：8
相关论文
共 50 条
  • [21] Lack of fibroblast growth factor 21 accelerates metabolic liver injury characterized by steatohepatities in mice
    Liu, Xingkai
    Zhang, Ping
    Martin, Robert C.
    Cui, Guozhen
    Wang, Guangyi
    Tan, Yi
    Cai, Lu
    Lv, Guoyue
    Li, Yan
    AMERICAN JOURNAL OF CANCER RESEARCH, 2016, 6 (05): : 1011 - 1025
  • [22] Fibroblast growth factor 21: A "rheostat" for metabolic regulation?
    She, Qin-Ying
    Bao, Jing-Fu
    Wang, Hui-Zhen
    Liang, Huixin
    Huang, Wentao
    Wu, Jing
    Zhong, Yiwen
    Ling, Hanxin
    Li, Aiqing
    Qin, Shu-Lan
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2022, 130
  • [23] Fibroblast Growth Factor 21-Metabolic Role in Mice and Men
    Staiger, Harald
    Keuper, Michaela
    Berti, Lucia
    de Angelis, Martin Hrabe
    Haering, Hans-Ulrich
    ENDOCRINE REVIEWS, 2017, 38 (05) : 468 - 488
  • [24] Plasma Concentrations of Fibroblast Growth Factors 21 and 19 in Patients with Cushing's Syndrome
    Durovcova, V.
    Marek, J.
    Hana, V.
    Matoulek, M.
    Zikan, V.
    Haluzikova, D.
    Kavalkova, P.
    Lacinova, Z.
    Krsek, M.
    Haluzik, M.
    PHYSIOLOGICAL RESEARCH, 2010, 59 (03) : 415 - 422
  • [25] The role of fibroblast growth factor 21 in atherosclerosis
    Kokkinos, John
    Tang, Shudi
    Rye, Kerry-Anne
    Ong, Kwok Leung
    ATHEROSCLEROSIS, 2017, 257 : 259 - 265
  • [26] Fibroblast growth factor 21: An emerging pleiotropic regulator of lipid metabolism and the metabolic network
    Li, Shuo
    Zou, Tiande
    Chen, Jun
    Li, Jiaming
    You, Jinming
    GENES & DISEASES, 2024, 11 (03)
  • [27] Emerging roles of fibroblast growth factor 21 in critical disease
    Yan, Fang
    Yuan, Li
    Yang, Fan
    Wu, Guicheng
    Jiang, Xiaobo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [28] Perturbations of Fibroblast Growth Factors 19 and 21 in Type 2 Diabetes
    Roesch, Stephen L.
    Styer, Amanda M.
    Wood, G. Craig
    Kosak, Zachary
    Seiler, Jamie
    Benotti, Peter
    Petrick, Anthony T.
    Gabrielsen, Jon
    Strodel, William E.
    Gerhard, Glenn S.
    Still, Christopher D.
    Argyropoulos, George
    PLOS ONE, 2015, 10 (02):
  • [29] Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23
    Degirolamo, Chiara
    Sabba, Carlo
    Moschetta, Antonio
    NATURE REVIEWS DRUG DISCOVERY, 2016, 15 (01) : 51 - 69
  • [30] Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis
    BonDurant, Lucas D.
    Potthoff, Matthew J.
    ANNUAL REVIEW OF NUTRITION, VOL 38, 2018, 38 : 173 - 196
12345